Analystreport

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Rigel Pharmaceuticals, Inc.  (RIGL) 
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.rigel.com